116 related articles for article (PubMed ID: 9212240)
21. Breast cancer gene therapy: transgenic immunotherapy.
Su N; Ojeifo JO; MacPherson A; Zwiebel JA
Breast Cancer Res Treat; 1994; 31(2-3):349-56. PubMed ID: 7881111
[TBL] [Abstract][Full Text] [Related]
22. [A study on characterization and tumorigenesis of an interleukin 2 gene transduced human breast carcinoma cell line].
Su N; Zhang X; Zwiebel JA
Zhonghua Bing Li Xue Za Zhi; 1996 Aug; 25(4):228-31. PubMed ID: 9275658
[TBL] [Abstract][Full Text] [Related]
23. Loss of tumorigenicity of human pancreatic carcinoma cells engineered to produce interleukin-2 or interleukin-4 in nude mice: a potentiality for cancer gene therapy.
Kimura M; Tagawa M; Takenaga K; Kondo F; Yamaguchi T; Saisho H; Nakagawara A; Sakiyama S
Cancer Lett; 1998 Jun; 128(1):47-53. PubMed ID: 9652792
[TBL] [Abstract][Full Text] [Related]
24. Constitutive production of IL-2 by human carcinoma cells, expression of IL-2 receptor, and tumor cell growth.
Lin WC; Yasumura S; Suminami Y; Sung MW; Nagashima S; Stanson J; Whiteside TL
J Immunol; 1995 Nov; 155(10):4805-16. PubMed ID: 7594483
[TBL] [Abstract][Full Text] [Related]
25. Human tumor antigen-specific T lymphocytes and interleukin-2-activated natural killer cells: comparisons of antitumor effects in vitro and in vivo.
Whiteside TL; Sung MW; Nagashima S; Chikamatsu K; Okada K; Vujanovic NL
Clin Cancer Res; 1998 May; 4(5):1135-45. PubMed ID: 9607570
[TBL] [Abstract][Full Text] [Related]
26. Dissimilar anti-tumour reactions induced by tumour cells engineered with the interleukin-2 or interleukin-15 gene in nude mice.
Di Carlo E; Meazza R; Basso S; Rosso O; Comes A; Gaggero A; Musiani P; Santi L; Ferrini S
J Pathol; 2000 Jun; 191(2):193-201. PubMed ID: 10861581
[TBL] [Abstract][Full Text] [Related]
27. H-2 antigen expression and sensitivity of BL6 melanoma cells to natural killer cell cytotoxicity.
Gorelik E; Gunji Y; Herberman RB
J Immunol; 1988 Mar; 140(6):2096-102. PubMed ID: 3126240
[TBL] [Abstract][Full Text] [Related]
28. [Basic studies on IL-2 gene therapy for head and neck carcinoma].
Mizuno H; Tsukuda M; Mochimatsu I; Daicho S; Nishimura G; Baba Y
Nihon Jibiinkoka Gakkai Kaiho; 1998 Jun; 101(6):799-806. PubMed ID: 9711080
[TBL] [Abstract][Full Text] [Related]
29. Effect of interleukin 1 receptor antagonist gene transduction on human melanoma xenografts in nude mice.
Weinreich DM; Elaraj DM; Puhlmann M; Hewitt SM; Carroll NM; Feldman ED; Turner EM; Spiess PJ; Alexander HR
Cancer Res; 2003 Sep; 63(18):5957-61. PubMed ID: 14522922
[TBL] [Abstract][Full Text] [Related]
30. Transduction of the IL2 gene into human acute leukemia cells: induction of tumor rejection without modifying cell proliferation and IL2 receptor expression.
Cignetti A; Guarini A; Carbone A; Forni M; Cronin K; Forni G; Gansbacher B; Foa R
J Natl Cancer Inst; 1994 May; 86(10):785-91. PubMed ID: 8169977
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-2 gene-transduced human leukemic cells induce major histocompatibility complex-restricted and -unrestricted anti-leukemic effectors in mixed lymphocyte-tumor cultures.
Cignetti A; Guarini A; Gillio Tos A; Reato G; Foa R
Cancer Gene Ther; 2000 Feb; 7(2):167-76. PubMed ID: 10770624
[TBL] [Abstract][Full Text] [Related]
32. Cellular mechanisms of interleukin-12-mediated neuroblastoma regression.
Redlinger RE; Shimizu T; Remy T; Alber S; Watkins SC; Barksdale EM
J Pediatr Surg; 2003 Feb; 38(2):199-204. PubMed ID: 12596103
[TBL] [Abstract][Full Text] [Related]
33. Transduction of human melanoma cell lines with the human interleukin-7 gene using retroviral-mediated gene transfer: comparison of immunologic properties with interleukin-2.
Miller AR; McBride WH; Dubinett SM; Dougherty GJ; Thacker JD; Shau H; Kohn DB; Moen RC; Walker MJ; Chiu R
Blood; 1993 Dec; 82(12):3686-94. PubMed ID: 8260705
[TBL] [Abstract][Full Text] [Related]
34. Systemic administration of recombinant interleukin-6 in mice induces proliferation of lymphoid cells in vivo.
Puri RK; Leland P
Lymphokine Cytokine Res; 1992 Jun; 11(3):133-9. PubMed ID: 1391232
[TBL] [Abstract][Full Text] [Related]
35. Interleukin 2-induced proliferation of murine natural killer cells in vivo.
Biron CA; Young HA; Kasaian MT
J Exp Med; 1990 Jan; 171(1):173-88. PubMed ID: 1688606
[TBL] [Abstract][Full Text] [Related]
36. Gene therapy of anaplastic thyroid carcinoma with a single-chain interleukin-12 fusion protein.
Shi Y; Parhar RS; Zou M; Baitei E; Kessie G; Farid NR; Alzahrani A; Al-Mohanna FA
Hum Gene Ther; 2003 Dec; 14(18):1741-51. PubMed ID: 14670125
[TBL] [Abstract][Full Text] [Related]
37. The combined action of IL-15 and IL-12 gene transfer can induce tumor cell rejection without T and NK cell involvement.
Di Carlo E; Comes A; Basso S; De Ambrosis A; Meazza R; Musiani P; Moelling K; Albini A; Ferrini S
J Immunol; 2000 Sep; 165(6):3111-8. PubMed ID: 10975824
[TBL] [Abstract][Full Text] [Related]
38. Cytokine gene therapy using adenovirally transduced, tumor-seeking activated natural killer cells.
Goding SR; Yang Q; Knudsen KB; Potter DM; Basse PH
Hum Gene Ther; 2007 Aug; 18(8):701-11. PubMed ID: 17678438
[TBL] [Abstract][Full Text] [Related]
39. IL-12 cDNA direct injection: antimetastatic effect from a single injection in a murine hepatic metastases model.
Weber SM; Qi C; Neal Z; Sondel P; Mahvi DM
J Surg Res; 2004 Dec; 122(2):210-7. PubMed ID: 15555620
[TBL] [Abstract][Full Text] [Related]
40. Recombinant human prolactin improves antitumor effects of murine natural killer cells in vitro and in vivo.
Sun R; Wei H; Zhang J; Li A; Zhang W; Tian Z
Neuroimmunomodulation; 2002-2003; 10(3):169-76. PubMed ID: 12481157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
